It is a trading public limited company based in New Delhi, Delhi, India, established in 2013.
2013 | New Delhi, Delhi, India | ActiveIberia Pharmaceuticals India Limited, a active public limited company, was established on 30 March 2013 in New Delhi, Delhi, India. Engaging in wholesale within the trade sector, it holds CIN: U24232DL2013PLC250040. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹30.00 Cr and a paid-up capital of ₹1.77 M.
Formerly known as Satnam Medical Agencies Private Limited, Iberia Pharmaceuticals India Limited. It upholds a compliant status. Employing 140 professional, Its leadership includes Rishab Jain (Whole-Time Director), Nitin Jain (Managing Director), Harmeet Kaur (Director). Past directors included Rishab Jain, Nitin Jain, Praveen Jain. It holds ₹10.25 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Property No. 4, Block-C, First Floor, Sector-8, Dwarka, New Delhi, Delhi, 110077.
U24232DL2013PLC250040
250040
30 March 2013
₹30.00 Cr
₹1.77 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Iberia Pharmaceuticals India Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rishab Jain | Whole-Time Director | 02 May 2021 | Current |
| Nitin Jain | Managing Director | 30 Mar 2013 | Current |
| Harmeet Kaur | Director | 01 Mar 2025 | Current |
| Atul Bhola | Director | 01 Mar 2025 | Current |
| Aditya Rungta | Director | 01 Mar 2025 | Current |
| Saurav Ojha | Whole-Time Director | 30 Sep 2023 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 20 Apr 2017 | Past |
| Pramod Abcsdd | Director | 28 Feb 2025 | Past |
| Pramod Abcsdd | Director | 02 May 2021 | Past |
| Pramod Abcsdd | Director | 28 Feb 2025 | Past |
| Pramod Abcsdd | Cfo | - | Past |
| Pramod Abcsdd | Cfo | - | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Iberia Pharmaceuticals India Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 53.87% increase. The company also saw a substantial improvement in profitability, with a 361.04% increase in profit. The company's net worth Soared by an impressive increase of 125.94%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Iberia Pharmaceuticals India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹102,508,998.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 Dec 2023 | Hdfc Bank Limited | ₹2.51 M | Open |
| 27 Dec 2023 | Others | ₹10.00 Cr | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Iberia Pharmaceuticals India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Iberia Pharmaceuticals India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Iberia Pharmaceuticals India's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Shripati Sharma was appointed as a Cfo was appointed as a Cfo on 15 Oct 2025 & has been associated with this company since 2 months 13 days . was recorded as a recent event.
A charge with Others of Rs. 10.00 Cr registered on 27 Dec 2023 with Charge ID 100850475 was modified on 06 Aug 2025. was recorded as a recent event.
Progress on Raj Kumar was appointed as a Company Secretary was appointed as a Company Secretary on 05 May 2025 & has been associated with this company since 7 months 23 days . was documented.
Harmeet Kaur was appointed as a Director was appointed as a Director on 01 Mar 2025 & has been associated with this company since 9 months 27 days . was recorded as a recent event.
The activity Atul Bhola was appointed as a Director was appointed as a Director on 01 Mar 2025 & has been associated with this company since 9 months 27 days . was completed.
Aditya Rungta was appointed as a Director was appointed as a Director on 01 Mar 2025 & has been associated with this company since 9 months 27 days . was recorded as a recent event.
The CIN of Iberia Pharmaceuticals India Limited is U24232DL2013PLC250040.
Iberia Pharmaceuticals India Limited is headquartered at Property No. 4, Block-C, First Floor, Sector-8, Dwarka, New Delhi, Delhi, 110077.
Iberia Pharmaceuticals India Limited was incorporated on 30 March 2013.
The current directors of Iberia Pharmaceuticals India Limited are
The primary industry of Iberia Pharmaceuticals India Limited is Trade.
Iberia Pharmaceuticals India Limited is unlisted.
The authorized capital of Iberia Pharmaceuticals India Limited is ₹30.00 Cr, and the paid-up capital is ₹1.77 M.
The compliance status of Iberia Pharmaceuticals India Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX